Ethermed key facts
as of Nov 2026- Developer of an artificial intelligence-based automation platform intended for prior authorization management purposes.
- Ethermed is valued at approximately $47.4M as of Nov 2026 (last reported valuation).
- It has raised $16.9M; the latest was Early Stage VC ($16.9M) in Apr 2026.
- Notable investors include MassChallenge, Gaingels, Jumpstart Ventures, Enfield Capital Partners, Blue Marlin Partners (Washington) — 8 tracked in total.
- Status: Privately Held (backing).
Ethermed's last reported valuation, Apr 2026. Nothing priced has surfaced since.
Ethermed funding rounds
No funding rounds for Ethermed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ethermed valuation
Ethermed's last reported valuation was $47.4 million in Apr 2026. No priced round, secondary trade or fund mark has surfaced since.
Ethermed investors
8 investors are on record for Ethermed, including MassChallenge, Gaingels, Jumpstart Ventures and Enfield Capital Partners.
About Ethermed
Developer of an artificial intelligence-based automation platform intended for prior authorization management purposes. The company's platform intercepts physician orders from electronic health record systems, extracts clinical data to determine specific payer requirements, performs evidence-based justification matching, and automatically populates and submits digital authorization forms directly to payers, enabling healthcare providers and insurance organizations to eliminate manual administrative paperwork, reduce treatment delays, and increase first-pass approval rates across diverse medical workflows.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2021
- Employees
- 29
- Website
- ethermed.ai/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.